False Claims Amendments Act of 2021 Continues to Wind Through Congress
Earlier this year, Senator Chuck Grassley and a bipartisan group of senators introduced the False Claims Amendment Act of 2021,…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Monthly Archives
December 2021
FDA Issues Two Draft Guidance Documents on Real-World Data
At the end of 2021, the United States Food and Drug Administration (FDA) issued two draft guidance documents that outline the…
Medical Practices Strained by Regulatory Burdens
A recent report from the Medical Group Management Association (MGMA) found that medical practices experienced greater regulatory…
Pharmacist and Two Pharmacies Agree to $1 Million False Claims Act…
On December 8, 2021, Riad Zahr, a Michigan pharmacist, along with two specialty owned pharmacies formerly owned and operated by…
CME Webcourse Details New Therapies, Guidelines for Managing Ulcerative…
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that has a severe impact on patients’ physical and psychosocial…
Policy and Medicine Compliance Update December 2021 — Compliance…
Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…
HHS OIG Updates Health Care Fraud Self-Disclosure Protocol
On November 8, 2021, the United States Department of Health and Human Services Office of Inspector General (HHS OIG) updated the…
DOJ Announces Two Connected False Claims Act Settlements
In early December 2021, the United States Department of Justice (DOJ) announced settlements with Dr. Jeffrey M. Gallups and…
Interim Final Rule with Request for Comments Released, Requiring More…
In mid-November 2021, several government agencies released a joint interim final rule with request for comments that requires…
OECD Issues New Bribery Recommendation
On Friday, November 26, 2021, the Organisation for Economic Co-operation and Development (OECD) adopted a new Recommendation for…